<DOC>
	<DOC>NCT00458328</DOC>
	<brief_summary>Z-338; PhaseIIb, Single-centre, Randomized, Double-blind, Placebo-controlled, Parallel group study in Subjects with Functional Dyspepsia, evaluate the motility of gastro-duodenum by ultrasound</brief_summary>
	<brief_title>The Effect of Z-338 in Subjects With Functional Dyspepsia</brief_title>
	<detailed_description />
	<mesh_term>Dyspepsia</mesh_term>
	<criteria>Postprandial fullness, upper abdominal bloating and/or early satiety should be at least moderate for 2 days or more at the 7 days at Visit 1. Upper abdominal pain, upper abdominal discomfort, postprandial fullness, upper abdominal bloating, early satiety, nausea, vomit and belching should be at least moderate for at least 2 symptoms for 2 days or more at the 7 days at Visit 1. Subjects that heartburn should be the most bothersome symptom Subjects presenting with primary complaints relieved by stool movements (IBS) Subjects with diabetes by treatment Subjects that heartburn should be more than moderate</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>